SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-023533
Filing Date
2024-07-26
Accepted
2024-07-26 10:50:20
Documents
1
Period of Report
2024-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 9132
  Complete submission text file 0001437749-24-023533.txt   11757
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Reporting) CIK: 0001274173 (see all company filings)

State of Incorp.: Y9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 241144364
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 151 DETROIT STREET DENVER CO 80206
Business Address 151 DETROIT STREET DENVER CO 80206 3033364030
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting) CIK: 0002030299 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 241144363